ACAnand Chundi

Anand Chundi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anand Chundi has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identifying common G protein–coupled receptor interacting proteins independent of heterotrimeric G proteins and β-arrestins

    by Chloe Hicks, Julia Gardner, Anand Chundi, Nicholas D Camarda, Chanpreet Jassal, Uyen Pham, Saisha Dhar, Hailey Rodriguez, J Fernando Bazan, Dylan Scott Eiger, et al.

    The canonical paradigm of G protein–coupled receptor (GPCR) signaling recognizes G proteins, β-arrestins, and GPCR kinases as the primary transducers that shape GPCR signaling. However, multiple studies have demonstrated that other interacting proteins regulate GPCR function in addition to these pathways, termed GPCR-interacting proteins (GIPs). The atypical chemokine receptor 3 (ACKR3) does not couple to G proteins, and β-arrestins have been shown to be dispensable for many of its functions. Here, we employed proximity labeling to identify proteins that interact with ACKR3 in cells devoid of β-arrestins. Among conserved proteins from our and several similar GPCR-based proximity labeling experiments, we discovered components of the endocytic machinery and other putative interacting proteins that can interact with GPCRs independent of G proteins and β-arrestins. Notably, we discovered that the bone morphogenetic protein 2–inducible kinase (BMP2K) interacts with ACKR3 in a phosphorylation-dependent manner that is distinct from its interaction with β-arrestin. We demonstrate BMP2K's ability to interact with many different GPCRs with varying dependency on β-arrestin. Using molecular dynamic simulations, we discovered an asparagine-proline-phenylephrine (NPF)-binding motif in BMP2K critical for its interaction with GPCRs and determined that this motif is conserved across many other GIPs. These findings reveal an expanded network of GIPs that interact with GPCRs independent of G proteins and β-arrestins, highlighting alternative mechanisms by which GPCR signaling may be transduced beyond canonical paradigms.

  • Open Access

    Small-molecule modulation of β-arrestins

    by Alem W. Kahsai, Natalia Pakharukova, Henry Y. Kwon, Kunal S. Shah, Caroline T. del Real, Bowie N. Shreiber, Jason G. Liang-Lin, Paul J. Shim, Mason A. Lee, Van A. Ngo, et al.

    β-Arrestins are multifunctional regulators of G-protein-coupled receptor (GPCR) signalling and orchestrate diverse downstream signalling events and physiological responses across the GPCR superfamily 1–3 . Although GPCR pharmacology has advanced to target orthosteric and allosteric sites, as well as G proteins and GPCR kinases, direct chemical tools to modulate β-arrestin activities have remained conspicuously absent. Here we report the identification of small-molecule inhibitors that selectively target β-arrestins and delineate their mechanism of action through integrated pharmacological, biochemical, biophysical and structural analyses. These inhibitors disrupt β-arrestin engagement with agonist-activated GPCRs, impairing desensitization, internalization and β-arrestin-dependent physiological functions while sparing G protein–receptor coupling. Cryo-electron microscopy, molecular dynamics simulations and structure-guided mutagenesis reveal that one modulator, Cmpd-5, engages a pocket within the central crest of β-arrestin1 formed by the middle, C and lariat loops, a critical receptor-binding interface, stabilizing a distinct conformation that is incompatible with full β-arrestin–receptor engagement. Together, these findings establish a mechanistic framework for β-arrestin modulation, reveal a novel allosteric site for structure-based drug design, and open new avenues for transducer-targeted, pathway-specific GPCR therapeutic agents.


  • Location-biased β-arrestin conformations direct GPCR signaling

    by Uyen Pham, Anand Chundi, Tomasz M. StęPniewski, Srikrishna Darbha, Dylan S. Eiger, Sonia Gazula, Julia Gardner, Chloe Hicks, Jana Selent, Sudarshan Rajagopal

    β-Arrestins are multifunctional, intracellular proteins that regulate the desensitization, internalization, and signaling of more than 800 G protein–coupled receptors (GPCRs) and interact with a diverse array of intracellular partners. Beyond the plasma membrane, GPCRs can initiate distinct signaling cascades from various subcellular locations, a phenomenon known as “location bias.” Here, we investigated how β-arrestins directed location-biased signaling of the angiotensin II type 1 receptor (AT1R) using bioluminescence resonance energy transfer (BRET) conformational biosensors and extracellular signal–regulated kinase (ERK) activity reporters. We found that, in response to the endogenous agonist angiotensin II and the β-arrestin–biased agonist TRV023, β-arrestin 1 and β-arrestin 2 adopted distinct conformations across different subcellular locations, which were associated with different ERK activation profiles. We also uncovered a population of receptor-free, activated β-arrestins in the plasma membrane that exhibited insensitivity to different agonists and promoted ERK activation at the plasma membrane independently of G proteins. These findings deepen our understanding of GPCR signaling complexity and highlight the nuanced roles of β-arrestins beyond traditional G protein pathways.


  • Biased Agonists of the Type 1 Angiotensin II Receptor Promote Distinct Subcellular β-Arrestin Conformations

    by Anand Chundi, Uyen Pham, Srikrishna Darbha, Sudarshan Rajagopal

    G protein-coupled receptors (GPCRs) are central to cellular signaling and therapeutic targeting. Ligands that activate the same GPCR can selectively activate some signaling pathways over others, a phenomenon termed biased agonism. Additionally, the same ligand and receptor complex can elicit distinct signaling profiles in different subcellular locations (location bias). Here, we examine how various biased agonists influence the recruitment of β-arrestins 1 and 2 induced by the angiotensin II type 1 receptor at the receptor, plasma membrane, and early endosomes. We also assessed β-arrestin conformational states at the receptor and plasma membrane. Using split luciferase and BRET assays, we demonstrate that angiotensin II, its G protein-biased analogs (TRV055, TRV056), and its β-arrestin-biased analogs (TRV023, TRV026, TRV027, TRV034) functionally stratify into two clusters. G protein-biased agonists and AngII predominantly favor a receptor-β-arrestin core complex conformation driven by engagement of the β-arrestin finger loop with the receptor core. In contrast, β-arrestin-biased agonists promote a tail complex configuration of receptor-associated β-arrestins. However, the conformations of β-arrestins monitored at the plasma membrane were found to be unaffected by ligand bias. Furthermore, balanced and G protein-biased ligands induced higher levels of ERK activation in subcellular locations (nucleus, cytosol, and early endosomes) over the β-arrestin-biased ligands, but equal ERK activity at the plasma membrane. Our findings highlight the interplay between ligand and location biases in dictating GPCR signaling, revealing new insights into the molecular mechanisms driving selective signal propagation.


  • Open Access

    Location-biased β-arrestin conformations direct GPCR signaling

    by Uyen Pham, Anand Chundi, Tomasz Maciej Stępniewski, Srikrishna Darbha, Dylan Scott Eiger, Sonia Gazula, Julia Gardner, Chloe Hicks, Jana Selent, Sudarshan Rajagopal

    β-arrestins are multifunctional intracellular proteins that regulate the desensitization, internalization and signaling of over 800 different G protein-coupled receptors (GPCRs) and interact with a diverse array of cellular partners 1,2 . Beyond the plasma membrane, GPCRs can initiate unique signaling cascades from various subcellular locations, a phenomenon known as “location bias” 3,4 . Here, we investigate how β-arrestins direct location-biased signaling of the angiotensin II type I receptor (AT1R). Using novel bioluminescence resonance energy transfer (BRET) conformational biosensors and extracellular signal-regulated kinase (ERK) activity reporters, we reveal that in response to the endogenous agonist Angiotensin II and the β-arrestin-biased agonist TRV023, β-arrestin 1 and β-arrestin 2 adopt distinct conformations across different subcellular locations, which are intricately linked to differential ERK activation profiles. We also uncover a population of receptor-free catalytically activated β-arrestins in the plasma membrane that exhibits insensitivity to different agonists and promotes ERK activation on the plasma membrane independent of G proteins. These findings deepen our understanding of GPCR signaling complexity and also highlight the nuanced roles of β-arrestins beyond traditional G protein pathways.


  • Phosphorylation patterns in the AT1R C-terminal tail specify distinct downstream signaling pathways

    by Clarice Gareri, Conrad T. Pfeiffer, Xue Jiang, Joao A. Paulo, Steven P. Gygi, Uyen Pham, Anand Chundi, Laura M. Wingler, Dean P. Staus, Tomasz Maciej Stepniewski, et al.

    Different ligands stabilize specific conformations of the angiotensin II type 1 receptor (AT1R) that direct distinct signaling cascades mediated by heterotrimeric G proteins or β-arrestin. These different active conformations are thought to engage distinct intracellular transducers because of differential phosphorylation patterns in the receptor C-terminal tail (the “barcode” hypothesis). Here, we identified the AT1R barcodes for the endogenous agonist AngII, which stimulates both G protein activation and β-arrestin recruitment, and for a synthetic biased agonist that only stimulates β-arrestin recruitment. The endogenous and β-arrestin–biased agonists induced two different ensembles of phosphorylation sites along the C-terminal tail. The phosphorylation of eight serine and threonine residues in the proximal and middle portions of the tail was required for full β-arrestin functionality, whereas phosphorylation of the serine and threonine residues in the distal portion of the tail had little influence on β-arrestin function. Similarly, molecular dynamics simulations showed that the proximal and middle clusters of phosphorylated residues were critical for stable β-arrestin–receptor interactions. These findings demonstrate that ligands that stabilize different receptor conformations induce different phosphorylation clusters in the C-terminal tail as barcodes to evoke distinct receptor-transducer engagement, receptor trafficking, and signaling.


  • GPCR kinases differentially modulate biased signaling downstream of CXCR3 depending on their subcellular localization

    by Julia Gardner, Dylan Scott Eiger, Chloe Hicks, Issac Choi, Uyen Pham, Anand Chundi, Ojas Namjoshi, Sudarshan Rajagopal

    Some G protein–coupled receptors (GPCRs) demonstrate biased signaling such that ligands of the same receptor exclusively or preferentially activate certain downstream signaling pathways over others. This phenomenon may result from ligand-specific receptor phosphorylation by GPCR kinases (GRKs). GPCR signaling can also exhibit location bias because GPCRs traffic to and signal from subcellular compartments in addition to the plasma membrane. Here, we investigated whether GRKs contributed to location bias in GPCR signaling. GRKs translocated to endosomes after stimulation of the chemokine receptor CXCR3 or other GPCRs in cultured cells. GRK2, GRK3, GRK5, and GRK6 showed distinct patterns of recruitment to the plasma membrane and to endosomes depending on the identity of the biased ligand used to activate CXCR3. Analysis of engineered forms of GRKs that localized to either the plasma membrane or endosomes demonstrated that biased CXCR3 ligands elicited different signaling profiles that depended on the subcellular location of the GRK. Each GRK exerted a distinct effect on the regulation of CXCR3 engagement of β-arrestin, internalization, and activation of the downstream effector kinase ERK. Our work highlights a role for GRKs in location-biased GPCR signaling and demonstrates the complex interactions between ligands, GRKs, and cellular location that contribute to biased signaling.


  • Open Access

    ACKR3 Proximity Labeling Identifies Novel G protein- and β-arrestin-independent GPCR Interacting Proteins

    by Chloe Hicks, Julia Gardner, Dylan Scott Eiger, Nicholas D. Camarda, Uyen Pham, Saisha Dhar, Hailey Rodriguez, Anand Chundi, Sudarshan Rajagopal

    The canonical paradigm of GPCR signaling recognizes G proteins and β-arrestins as the two primary transducers that promote GPCR signaling. Recent evidence suggests the atypical chemokine receptor 3 (ACKR3) does not couple to G proteins, and β-arrestins are dispensable for some of its functions. Here, we employed proximity labeling to identify proteins that interact with ACKR3 in cells devoid of β-arrestin. We identified proteins involved in the endocytic machinery and evaluated a subset of proteins conserved across several GPCR-based proximity labeling experiments. We discovered that the bone morphogenic protein 2-inducible kinase (BMP2K) interacts with many different GPCRs with varying dependency on β-arrestin. Together, our work highlights the existence of modulators that can act independently of G proteins and β-arrestins to regulate GPCR signaling and provides important evidence for other targets that may regulate GPCR signaling. Graphical


  • Open Access

    Location Biased G Protein-Coupled Receptor Signaling Modulates Distinct Spatial Conformations of β-arrestins

    by Anand Chundi, Uyen Pham, Sudarshan Rajagopal

    ID 53127 Poster Board 559 G Protein-Coupled receptors (GPCRs) are the largest superfamily of transmembrane receptors. They are ubiquitously expressed in the body and canonically signal through various effectors, including heterotrimeric G proteins, β-arrestins, and GPCR kinases (GRKs). Research has shown that the same receptor, when bound to different ligands, can selectively activate some signaling pathways over others, a concept known as ‘biased agonism’. Additionally, GPCRs possess distinct signaling profiles at different subcellular locations, a phenomenon termed ‘location bias’. However, the molecular mechanisms underlying the role of location bias in GPCR signaling are not well understood. To elucidate these mechanisms, we assessed the subcellular trafficking patterns and location-specific conformations of β-arrestins 1 and 2 following stimulation of the Angiotensin II type 1 receptor (AT1R) with the endogenous ligand angiotensin II (AngII) and a β-arrestin-biased ligand TRV120023. Utilizing the NanoBiT complementation assay and bioluminescence resonance energy transfer (BRET), β-arrestins 1 and 2 were found to be differentially trafficked to the plasma membrane and endosomes following AT1R stimulation. Additionally, a pool of β-arrestins was found to localize at the plasma membrane despite receptor internalization, indicating catalytic activation of β-arrestins by the receptor. Using a novel conformational BRET biosensor called NanoBiT FLAsH, we revealed that β-arrestins 1 and 2 adopt distinct, location-dependent conformations at the plasma membrane, lipid rafts, and early endosomes. Additionally, the catalytically active pool of β-arrestins at the plasma membrane was found to possess different conformations from receptor-associated β-arrestins at the plasma membrane or endosomes. These findings suggest that location-dependent GPCR signaling modulates the conformation of β-arrestins, resulting in differential signaling outcomes.